Skip to content

Clinical trials

Terminated Phase 1/2 Gastrointestinal Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Gastrointestinal Neoplasms Phase: Phase 1/2 Status: Terminated Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20111
20171
20182
20191
20202
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated10

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)2
Bolt Biotherapeutics, Inc.1
Columbia University1
Generic Devices Consulting, Inc.1
Institut Cancerologie de l'Ouest1
Kyowa Kirin Co., Ltd.1
Repos Pharma1
Theseus Pharmaceuticals1
Thomas Jefferson University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Gastrointestinal Neoplasms10
Colorectal Neoplasms4
Neoplasms4
Colonic Neoplasms3
Digestive System Diseases3
Digestive System Neoplasms3
Gastrointestinal Diseases3
Stomach Neoplasms3
Colonic Diseases2
Intestinal Diseases2

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.